Fang P, Ye Z, Li R, She D, Zong G, Zhang L, . . . Zhang K. (2023). Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP. Dove Medical Press.
Chicago Style (17th ed.) CitationFang P, Ye Z, Li R, She D, Zong G, Zhang L, Xue Y, and Zhang K. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating MicroRNA-29b-3p/SLMAP. Dove Medical Press, 2023.
MLA (9th ed.) CitationFang P, et al. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating MicroRNA-29b-3p/SLMAP. Dove Medical Press, 2023.
Warning: These citations may not always be 100% accurate.